MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/srep36182

Медицинская библиотека · Scientific reports · 2016

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.

Masat Elisa, Laforêt Pascal, De Antonio Marie, Corre Guillaume, Perniconi Barbara, Taouagh Nadjib, Mariampillai Kuberaka, Amelin Damien, Mauhin Wladimir, Hogrel Jean-Yves, Caillaud Catherine, Ronzitti Giuseppe, Puzzo Francesco, Kuranda Klaudia, Colella Pasqualina, Mallone Roberto, Benveniste Olivier, Mingozzi Federico, French Pompe Registry Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Immunogenicity of recombinant human acid-alpha glucosidase (rhGAA) in enzyme replacement therapy (ERT) is a safety and efficacy concern in the management of late-onset Pompe disease (LOPD). However, long-term effects of ERT on humoral and cellular responses to rhGAA are still poorly understood. To better understand the impact of immunogenicity of rhGAA on the efficacy of ERT, clinical data and blood samples from LOPD patients undergoing ERT for >4 years (n = 28) or untreated (n = 10) were collected and analyzed. In treated LOPD patients, anti-rhGAA antibodies peaked within the first 1000 days of ERT, while long-term exposure to rhGAA resulted in clearance of antibodies with residual production of non-neutralizing IgG. Analysis of  T cell responses to rhGAA showed detectable T cell reactivity only after in vitro restimulation. Upregulation of several cytokines and chemokines was detectable in both treated and untreated LOPD subjects, while IL2 secretion was detectable only in subjects who received ERT. These results indicate that long-term ERT in LOPD patients results in a decrease in antibody titers and residual production of non-inhibitory IgGs. Immune responses to GAA following long-term ERT do not seem to affect efficacy of ERT and are consistent with an immunomodulatory effect possibly mediated by regulatory T cells.

Для цитирования: Masat Elisa, Laforêt Pascal, De Antonio Marie, Corre Guillaume, Perniconi Barbara, Taouagh Nadjib, Mariampillai Kuberaka, Amelin Damien, Mauhin Wladimir, Hogrel Jean-Yves, Caillaud Catherine, Ronzitti Giuseppe, Puzzo Francesco, Kuranda Klaudia, Colella Pasqualina, Mallone Roberto, Benveniste Olivier, Mingozzi Federico, French Pompe Registry Study Group. Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.. Scientific reports. 2016. DOI: 10.1038/srep36182.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.